ZECHENG ELECTRONICS
837821
Ji Yao Holding Group
300108
Shenzhen Bestek Technology
300822
Jiangsu Canlon Building Materials
300715
Shanghai Hajime Advanced Material Technology
301000
CN Stock MarketDetailed Quotes
300841 Chengdu Kanghua Biological Products
- 51.30
- -0.31-0.60%
Market Closed Jan 9 15:00 CST
6.82BMarket Cap12.49P/E (TTM)
51.91High50.91Low11.52KlotVolume51.21Open51.61Pre Close59.26MTurnover0.96%Turnover Ratio13.39P/E (Static)132.95MShares79.0052wk High2.00P/B6.18BFloat Cap42.8152wk Low61.93Limit Up120.49MShs Float439.88Historical High41.29Limit Down1.94%Amplitude33.51Historical Low2.00Dividend TTM51.46Avg Price6.10KlotAsk3.90%Div YieldTTM100Lot Size5.07KlotBid
Chengdu Kanghua Biological Products Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 1.15%1.01B | 1.74%628.54M | -1.14%261.62M | 48.28%1.49B | 41.76%999.22M | 50.17%617.8M | 58.85%264.63M | 20.03%1.01B | 30.60%704.86M | 32.92%411.41M |
| Cash received relating to other operating activities | 1,095.17%117.84M | 834.68%115.6M | 3,418.88%110.26M | -4.76%20.71M | -52.81%9.86M | -17.35%12.37M | -58.52%3.13M | -26.57%21.75M | 9.82%20.89M | 15.60%14.96M |
| Cash inflows from operating activities | 11.84%1.13B | 18.08%744.13M | 38.89%371.88M | 47.16%1.51B | 39.04%1.01B | 47.80%630.17M | 53.76%267.76M | 18.44%1.03B | 29.89%725.75M | 32.23%426.37M |
| Goods services cash paid | -55.60%37.15M | -57.22%25.93M | -81.64%6.28M | 36.45%89.05M | -4.75%83.66M | -3.90%60.6M | 9.23%34.18M | -45.72%65.26M | -5.65%87.84M | 38.88%63.06M |
| Staff behalf paid | 9.99%134.73M | 13.72%98.54M | 15.84%59.53M | 11.89%150.39M | 10.30%122.5M | 14.82%86.66M | 14.25%51.39M | 28.91%134.41M | 37.70%111.05M | 40.25%75.47M |
| All taxes paid | 55.33%126.74M | 64.85%93.78M | 103.62%55.62M | -26.65%105.34M | -31.06%81.6M | -22.97%56.89M | -47.82%27.31M | 21.08%143.61M | 35.32%118.35M | 50.35%73.85M |
| Cash paid relating to other operating activities | 26.44%576.96M | 15.06%350.09M | 10.07%151.87M | 21.36%595.69M | 17.34%456.31M | 8.28%304.26M | -12.30%137.98M | 24.11%490.86M | 36.25%388.88M | 45.34%280.99M |
| Cash outflows from operating activities | 17.67%875.58M | 11.79%568.34M | 8.94%273.29M | 12.75%940.46M | 5.37%744.07M | 3.05%508.4M | -12.27%250.87M | 12.94%834.14M | 29.18%706.12M | 44.40%493.36M |
| Net cash flows from operating activities | -4.56%252.92M | 44.37%175.79M | 483.65%98.59M | 194.36%573.98M | 1,250.24%265.01M | 281.76%121.77M | 115.11%16.89M | 49.62%194.99M | 62.06%19.63M | -248.60%-66.99M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | --101.12M | --100M | --50M | -76.88%50M | ---- | ---- | ---- | -77.45%216.25M | -72.24%216.25M | -50.74%216.25M |
| Cash received from returns on investments | --908.38K | --751.29K | ---- | -32.38%348.75K | ---- | ---- | ---- | -88.91%515.76K | -87.30%546.7K | -81.68%546.7K |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -90.00%400 | ---- | ---- | 2,233.56%36.59K | -93.78%4K | --4K | ---- | -84.32%1.57K | --64.32K | ---- |
| Cash inflows from investing activities | 2,550,573.91%102.03M | 2,518,682.29%100.75M | --50M | -76.76%50.39M | -100.00%4K | -100.00%4K | ---- | -77.51%216.77M | -72.31%216.86M | -50.95%216.8M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -8.45%96.58M | -26.56%56.24M | -40.94%35.79M | -62.48%157.27M | -66.73%105.5M | -58.36%76.58M | -15.34%60.6M | 33.11%419.23M | 27.78%317.13M | 73.29%183.91M |
| Cash paid to acquire investments | 1,438.46%100M | 1,165.82%100M | --100M | -73.10%56.5M | -96.75%6.5M | -96.05%7.9M | ---- | -75.30%210M | -74.69%200M | -56.55%200M |
| Cash outflows from investing activities | 75.52%196.58M | 84.94%156.24M | 124.08%135.79M | -66.03%213.77M | -78.34%112M | -77.99%84.48M | -64.68%60.6M | -46.00%629.23M | -50.20%517.13M | -32.22%383.91M |
| Net cash flows from investing activities | 15.57%-94.55M | 34.32%-55.49M | -41.57%-85.79M | 60.39%-163.39M | 62.70%-111.99M | 49.45%-84.48M | 64.68%-60.6M | -104.67%-412.46M | -17.69%-300.27M | -34.34%-167.11M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | ---- | ---- | -72.93%1.4M | ---- | --5.17M | --5.17M | --5.17M |
| Cash from borrowing | 56.61%206.34M | 26.25%166.34M | 57.77%36.34M | 42.22%221.75M | -1.87%131.75M | -0.32%131.75M | -42.41%23.04M | --155.93M | --134.26M | --132.18M |
| Cash inflows from financing activities | 56.61%206.34M | 24.93%166.34M | 57.77%36.34M | 37.65%221.75M | -5.51%131.75M | -3.05%133.15M | -42.41%23.04M | --161.1M | --139.43M | --137.35M |
| Borrowing repayment | 56.23%180.75M | 76.04%180.75M | --17.04M | 423.08%156.93M | --115.7M | --102.68M | ---- | --30M | ---- | ---- |
| Dividend interest payment | 276.76%262.58M | 278.21%262.6M | 352.38%1.41M | -47.64%71.63M | -48.62%69.69M | -48.29%69.43M | 1,569.64%311.2K | 52.02%136.82M | 50.71%135.64M | 49.19%134.27M |
| Cash payments relating to other financing activities | 63,937.88%200M | --114.37M | --62.43M | -99.54%312.31K | -99.54%312.31K | ---- | ---- | 18.20%67.84M | 7,295.22%67.53M | 16,486.99%60.26M |
| Cash outflows from financing activities | 246.43%643.33M | 224.05%557.72M | 25,888.57%80.88M | -2.47%228.87M | -8.60%185.7M | -11.52%172.11M | -93.93%311.2K | 59.20%234.66M | 123.48%203.18M | 115.27%194.53M |
| Net cash flows from financing activities | -710.00%-436.99M | -904.72%-391.38M | -295.96%-44.53M | 90.33%-7.12M | 15.37%-53.95M | 31.87%-38.95M | -34.84%22.73M | 50.09%-73.56M | 29.88%-63.74M | 36.72%-57.18M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 4,681.06%1.59M | 176,850.02%1.78M | 2,104.30%195.15K | -161.14%-69.07K | -137.49%-34.77K | -103.17%-1.01K | -785.37%-9.74K | 933.53%112.98K | 1,012.53%92.75K | 440.54%31.8K |
| Net increase in cash and cash equivalents | -379.74%-277.02M | -16,059.93%-269.29M | -50.23%-31.54M | 238.67%403.41M | 128.76%99.03M | 99.43%-1.67M | 91.55%-20.99M | -33.08%-290.92M | -3.10%-344.29M | -24.47%-291.25M |
| Add:Begin period cash and cash equivalents | 59.54%1.04B | 63.43%1.04B | 63.43%1.04B | -31.39%635.96M | -29.71%651.46M | -31.39%635.96M | -31.39%635.96M | -19.08%926.88M | -19.08%926.88M | -19.08%926.88M |
| End period cash equivalent | 1.58%762.34M | 21.41%770.07M | 63.88%1.01B | 63.43%1.04B | 28.82%750.49M | -0.21%634.29M | -9.35%614.97M | -31.39%635.96M | -28.21%582.59M | -30.27%635.63M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
